Comparison

DDIT4 Polyclonal Antibody

Item no. E-AB-11148-200
Manufacturer Elabscience
Amount 200 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications IHC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias DDIT4, DDIT4, Dig2, DNA damage inducible transcript 4, DNA damage inducible transcript 4 protein, DNA damage-inducible transcript 4 protein, FLJ20500, HIF 1 responsive protein RTP801, HIF 1 responsive RTP801, HIF-1 responsive protein RTP801, Protein regulated in development and DNA damage response 1, REDD-1, REDD1, RTP801
Similar products RTP801, DDIT4, REDD1, DNA damage-inducible transcript 4 protein, HIF-1 responsive protein RTP801, Protein regulated in development and DNA damage response 1, Dig2, FLJ20500, REDD-1, DNA damage inducible transcript 4, DNA damage inducible transcript 4 protein, HIF 1 responsive protein RTP801, HIF 1 responsive RTP801
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
DDIT4
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Manufacturer - Research Areas
Cancer, Cardiovascular, Epigenetics and Nuclear Signaling, Metabolism
Background
REDD-1, also designated DNA-damage-inducible transcript 4, dig2 or RTP801, is thought to function in the regulation of reactive oxygen species (ROS). REDD-1 expression has also been linked to apoptosis, Ab toxicity and the pathogenesis of ischemic diseases. As an HIF-1-responsive gene, REDD-1 exhibits strong hypoxia-dependent upregulation in ischemic cells of neuronal origin. In response to stress due to DNA damage and glucocorticoid treatment, REDD-1 is upregulated at the transcriptional level. REDD-1 negatively regulates the mammalian target of Rapamycin (mTOR), a serine/threonine kinase often referred to as FRAP. It is crucial in the coupling of extra- and intracellular cues to FRAP regulation. The absence of REDD-1 is associated with the development of retinopathy, a major cause of blindness.
Concentration
0.8 mg/mL
Buffer
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method
Affinity purification
Recommended Dilution
IHC 1:50-1:200
Santa Cruz #
sc-46034, sc-46033, sc-67051
Abbreviation
DDIT4
Clonality
Polyclonal
Immunogen
Recombinant protein of human DDIT4
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?